Parkside Investments LLC Sells 2,936 Shares of Thermo Fisher Scientific Inc (TMO)
Parkside Investments LLC cut its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 13.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,134 shares of the medical research company’s stock after selling 2,936 shares during the quarter. Thermo Fisher Scientific comprises about 2.0% of Parkside Investments LLC’s holdings, making the stock its 17th largest position. Parkside Investments LLC’s holdings in Thermo Fisher Scientific were worth $3,431,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of TMO. Proficio Capital Partners LLC grew its position in Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC purchased a new position in Thermo Fisher Scientific during the second quarter worth about $108,000. Shine Investment Advisory Services Inc. purchased a new position in Thermo Fisher Scientific during the second quarter worth about $113,000. Ropes Wealth Advisors LLC grew its position in Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 97 shares in the last quarter. Finally, Atlantic Trust LLC purchased a new position in Thermo Fisher Scientific during the second quarter worth about $138,000. Institutional investors and hedge funds own 86.16% of the company’s stock.
In other news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. Insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Inc (NYSE:TMO) traded down $0.56 during midday trading on Monday, hitting $192.20. The stock had a trading volume of 1,335,400 shares, compared to its average volume of 1,545,250. Thermo Fisher Scientific Inc has a 12 month low of $139.32 and a 12 month high of $201.20. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The company has a market cap of $77,071.31, a price-to-earnings ratio of 21.12, a PEG ratio of 1.76 and a beta of 1.06.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the company posted $2.03 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% on a year-over-year basis. sell-side analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.
A number of equities analysts have recently issued reports on the company. Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Leerink Swann upped their price objective on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Finally, Cowen reiterated an “outperform” rating and issued a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus target price of $205.21.
ILLEGAL ACTIVITY NOTICE: “Parkside Investments LLC Sells 2,936 Shares of Thermo Fisher Scientific Inc (TMO)” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/parkside-investments-llc-sells-2936-shares-of-thermo-fisher-scientific-inc-tmo/1743299.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.